You are here:
NICE
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Osteoporosis
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women
Technology appraisal guidance
Reference number:
TA160
Published:
27 October 2008
Last updated:
07 February 2018
Guidance
Tools and resources
Evidence
History
Research recommendations coming out of this guidance
There are no research recommendations for TA160